Is anyone listening? Variation in PSA screening among providers for men 75+ before and after United States preventive services task force recommendations against it: A retrospective cohort study

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Goodwin, James S ^a,b   Jaramillo, Elizabeth ^a   Yang, Liu ^a   Kuo, Yong Fang ^a,b   Tan, Alai ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AFRICAN AMERICAN; AGE; AGED; ARTICLE; CANCER SCREENING; CAUCASIAN; CERTIFICATION; CLINICAL ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CORRELATION COEFFICIENT; GENERAL PRACTITIONER; HISPANIC; HUMAN; MALE; MEDICARE; PROSTATE CANCER; RETROSPECTIVE STUDY; SOCIAL STATUS; UNITED STATES; ADVISORY COMMITTEE; LEGISLATION AND JURISPRUDENCE; MASS SCREENING; METABOLISM; PATHOLOGY; PROSTATIC NEOPLASMS; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

ADVISORY COMMITTEES; AGED; AGED, 80 AND OVER; HUMANS; MALE; MASS SCREENING; PHYSICIANS, PRIMARY CARE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; TEXAS;

EID: 84954432175     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107352     Document Type: Article

References (48)

1. Welch HG, Albertsen PC (2009) Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005. J Natl Cancer Instit 101: 1325-1329.
2. Howrey BT, Kuo YF, Lin YL, Goodwin JS (2013) The impact of PSA screening on prostate cancer mortality and overdiagnosis of prostate cancer in the United States. J Gerontol A Bio Sci Med Sci 68: 56-61.
3. U.S. Preventives Services Task Force (2008) Screening for prostate cancer: U.S. Preventives Services Task Force recommendation statement. Ann Intern Med 149: 185-191.
4. Carter HB, Albertsen PC, Barry MJ, Etzioni R, Freedland SJ, et al. (2013) Early detection of prostate cancer: AUA Guideline. J Urol 190: 419-426.
5. Smith RA, Cokkinides V, Eyre HJ (2006) American Cancer Society guidelines for the early detection of cancer, 2006. CA Cancer J Clin 56: 11-25.
6. American Urological Association (AUA) (2000) Prostate-specific antigen (PSA) best practice policy. Oncology (Williston Park) 14: 267-272.
7. Guerra CE, Gimotty PA, Shea JA, Pagán JA, Schwartz JS, et al. (2008) Effect of guidelines on primary care physician use of PSA screening: results from the Community Tracking Study Physician Survey. Med Decis Making 28: 681-689.
8. Bynum J, Song Y, Fisher E (2010) Variation in prostate-specific antigen screening in men aged 80 and older in fee-for-service Medicare. J Am Geriatr Soc 58: 674-680.
9. Walter LC, Bertenthal D, Lindquist K, Konety BR (2006) PSA screening among elderly men with limited life expectancies. JAMA 296: 2336-2342.
10. Jaramillo E, Tan A, Yang L, Kuo YF, Goodwin JS (2013) Variation among primary care physicians in prostate specific antigen testing of older men. JAMA 310: 1622-1624.
11. Ross JS, Wang R, Long JB, Gross CP, Ma X (2012) Impact of the 2008 US Preventive Services Task Force recommendations to discontinue prostate cancer screening among male Medicare beneficiaries. Arch Intern Med 172: 1601-1603.
12. Howard DH, Tangka FK, Guy GP, Ekweume DU, Lipscomb J (2013) Prostate cancer screening in men ages 75 and older fell by 8 percentage points after task for recommendation. Health Affairs 32: 596-602.
13. Steinbrook R (2007) Guidance for guidelines. N Engl J Med 356: 331-333.
14. Gerber AS, Patashnik EM, Doherty D, Dowling C (2010) A national survey reveals public skepticism about research-based treatment guidelines. Health Aff (Millwood) 10: 1882-1884.
15. Hawley ST, Earp JA, O'Malley M, Ricketts TC (2000) The role of physician recommendation in women's mammography use: is it a 2-stage process? Med Care 38: 392-403.
16. Nichols C, Holt CL, Shipp M, Eloubeidi M, Fouad MN, et al. (2009) Physician knowledge, perceptions of barriers, and patient colorectal cancer screening practices. Am J Med Qual 24: 116-122.
17. Wennberg JE (2010) Tracking medicine: A researcher's quest to understand health care. New York: Oxford University Press. 344 p.
18. Sirovich B, Gallagher PM, Wennberg DE, Fisher ES (2008) Discretionary decision making by primary care physicians and the cost of U.S. health care. Health Aff (Millwood) 27: 813-823.
19. Hofer TP, Hayward RA, Greenfield S, Wagner EH, Kaplan SH, et al. (1999) The unreliability of individual physician ''report cards'' for assessing the costs and quality of care of a chronic disease. JAMA 281: 2098-2105.
20. Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, et al. (2005) Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 43: 1130-1139.
21. Elixhauser A, Steiner C, Harris DR, Coffey RM (1998) Comorbidity measures for use with administrative data. Med Care 36: 8-27.
22. Shah BR, Hux JE, Laupacis A, Zinman B, Cauch-Dudek K, et al. (2007) Administrative data algorithms can describe ambulatory physician utilization. Health Serv Res 42: 1783-1796.
23. US Department of Agriculture Economic Research Service (2013) Rural-Urban Continuum Codes. USDA. http://www.ers.usda.gov/data-products/ruralurban- continuum-codes/documentation.aspx. Accessed 20 June 2014.
24. Song Y, Skinner J, Bynum J, Sutherland J, Wennberg JE, et al. (2010) Regional variations in diagnostic practices. N Eng J Med 363: 45-53.
25. Tan A, Kuo YF, Elting LS, Goodwin JS (2013) Refining physician quality indicators for screening mammography in older women: Distinguishing appropriate use from overuse. J Am Geriatr Soc 61: 380-387.
26. Singal AK, Lin YL, Kuo YF, Riall T, Goodwin JS (2013) Primary care physicians and disparities in colorectal cancer screening in the elderly. Health Serv Res 48: 95-113.
27. Cowen ME, Strawderman RL (2002) Quantifying the physician contribution to managed care pharmacy expenses: a random effects approach. Med Care 40: 650-661.
28. Beaulieu MD, Blais R, Jacques A, Battista RN, Lebeau R, et al. (2001) Are patients suffering from stable angina receiving optimal medical treatment? QJM 94: 301-308.
29. Sixma HJ, Spreeuwenberg PM, van der Pasch MA (1998) Patient satisfaction with the general practitioner: a two-level analysis. Med Care 36: 212-229.
30. Chen J, Rathore SS, Wang Y, Radford MJ, Krumholz HM (2006) Physician board certification and the care and outcomes of elderly patients with acute myocardial infarction. J Gen Intern Med 21: 238-244.
31. Norcini J, Lipner R, Kimball H (2001) The certification status of generalist physicians and the mortality of their patients after acute myocardial infarction. Acad Med 76: S21-S23.
32. Tasian GE, Cooperberg MR, Potter MD, Cowan JE, Greene KL, et al. (2012) PSA screening: determinants of primary-care physician practice patterns. Prostate Cancer Prostatic Dis 15: 189-194.
33. Pollack CE, Noronha G, Green GE, Bhavsar NA, Carter HB (2012) Primary care provider's response to the US Preventive Services Task Force draft recommendations on screening for prostate cancer. Arch Intern Med 172: 668-670.
34. Schwartz LM, Woloshin S, Fowler FJ Jr, Welch HG (2004) Enthusiasm for cancer screening in the United States. JAMA 291: 71-78.
35. Torke AM, Schwartz PH, Holtz LR, Montz K, Sachs GA (2013) Older adults and forgoing cancer screening: ''I think it would be strange.'' JAMA Intern Med 173: 526-531.
36. AAFP, USPSTF Issue Final Recommendation Against Routine PSA-based Screening for Prostate Cancer. http://www.aafp.org/news/health-of-thepublic/20120522psascreenrec.html. Accessed 7/16/2014.
37. Moyer VA, U.S. Preventive Services Task Force (2012) Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med; 157: 120-134.
38. Murphy DG, Ahlering T, Catalona WJ, Crowe H, Crow J, et al. (2014) The Melbourne Concensus Statement on the early detection of prostate cancer. BJUI International; 113: 186-188.
39. LUGPA Position Statement: PSA Screening. http://lugpa.org/latest-news/lugpa-position-statement-psa-screening/, accessed 7/16/14.
40. Tan A, Kuo Y, Goodwin JS (2013) Predicting life expectancy for community dwelling older adults using Medicare claims data. Am J Epidemiol; 178: 974-83.
41. Pasad SM, Drazer MW, Dezheng H, Hu JC, Eggener SE (2012) 2008 US Preventive Task Force recommendations and prostate cancer screening rates. JAMA 307: 1692-1694.
42. Zeliadt SB, Hoffman RM, Etzioni R, Gore JL, Kessler LG, et al. (2011) Influence of publication of US and European prostate cancer screening trials on PSA testing practices. J Natl Cancer Inst 103: 520-523.
43. Goodwin JS, Tan A, Jaramillo E, Kuo YF (2013) Prostate-specific antigen testing in men aged 40-64 years: impact of publication of clinical trials. J Natl Cancer Inst 105: 743-745.
44. Katz MH (2012) Overuse of health care: where are the data? Arch Intern Med 172: 178. doi:10.1001/archinternmed.2011.1253.
45. Lee SJ, Walter LC (2011) Quality indicators for older adults: preventing unintended harms. JAMA 306: 1481-1482.
46. Medicare Learning Network (2012) Reminder - Medicare provides coverage of prostate cancer screening for eligible Medicare beneficiaries. MLN Matters Number: SE0709. Centers for Medicare and Medicaid Services. http://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MN/MLNMattersArticles/downloads/SE0709.pdf. Accessed 20 June 2014.
47. Wallner L, Frencher S, Hsu JW, Loo R, Huang J, et al. (2012) Prostate cancer screening trends in a large, integrated health care system. Perm J 16: 4-9.
48. Adams JL, Mehrotra A, Thomas JW, McGlynn EA (2010) Physician cost profiling- reliability and risk of misclassification. N Engl J Med 362: 1014-1021